Insider Buying: BioSig Technologies, Inc. (NASDAQ:BSGM) Insider Purchases $42,522.48 in Stock

BioSig Technologies, Inc. (NASDAQ:BSGMGet Rating) insider Gray Fleming bought 36,036 shares of the company’s stock in a transaction on Wednesday, August 24th. The stock was bought at an average cost of $1.18 per share, with a total value of $42,522.48. Following the completion of the acquisition, the insider now owns 36,036 shares of the company’s stock, valued at approximately $42,522.48. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

BioSig Technologies Stock Down 3.5 %

Shares of BioSig Technologies stock opened at $1.09 on Friday. BioSig Technologies, Inc. has a 12-month low of $0.50 and a 12-month high of $4.10. The company has a 50-day moving average of $0.76 and a two-hundred day moving average of $0.98.

BioSig Technologies (NASDAQ:BSGMGet Rating) last issued its earnings results on Monday, August 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.04. BioSig Technologies had a negative net margin of 22,438.64% and a negative return on equity of 253.64%. As a group, equities research analysts forecast that BioSig Technologies, Inc. will post -0.64 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Warberg Asset Management LLC purchased a new position in shares of BioSig Technologies during the 2nd quarter worth approximately $43,000. Advisor Group Holdings Inc. increased its stake in shares of BioSig Technologies by 394.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 85,859 shares of the company’s stock worth $99,000 after purchasing an additional 68,509 shares in the last quarter. Commonwealth Equity Services LLC increased its stake in shares of BioSig Technologies by 24.2% during the 1st quarter. Commonwealth Equity Services LLC now owns 125,705 shares of the company’s stock worth $144,000 after purchasing an additional 24,500 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its stake in shares of BioSig Technologies by 17.6% during the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 240,589 shares of the company’s stock worth $537,000 after purchasing an additional 36,000 shares in the last quarter. 9.46% of the stock is owned by hedge funds and other institutional investors.

BioSig Technologies Company Profile

(Get Rating)

BioSig Technologies, Inc, together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time.

See Also

Insider Buying and Selling by Quarter for BioSig Technologies (NASDAQ:BSGM)

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.